SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
6.61
-0.32 (-4.62%)
At close: Aug 10, 2026, 4:00 PM EDT
6.52
-0.09 (-1.36%)
After-hours: Aug 10, 2026, 7:34 PM EDT
SciSparc Employees
SciSparc had 3 employees as of December 31, 2025. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
$285,333
Profits / Employee
-$4,059,667
Market Cap
3.79M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 1 | 50.00% |
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Dec 31, 2021 | 3 | 1 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| PMGC Holdings | 34 |
| TransCode Therapeutics | 12 |
| Dermata Therapeutics | 9 |
| Revelation Biosciences | 9 |
| Galmed Pharmaceuticals | 6 |
| Mustang Bio | 4 |
| Creative Medical Technology Holdings | 4 |
SPRC News
- 5 days ago - SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome - GlobeNewsWire
- 5 days ago - NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome - TheNewswire
- 10 days ago - SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics - GlobeNewsWire
- 12 days ago - Scisparc Ltd trading resumes - TheFly
- 12 days ago - Scisparc Ltd trading halted, volatility trading pause - TheFly
- 12 days ago - SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company - GlobeNewsWire
- 14 days ago - SciSparc to target agentic artificial intelligence market - TheFly
- 14 days ago - SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity - GlobeNewsWire